Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

B2M mutation + MSI-H/dMMR

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

CEACAM5 underexpression + MSI-H/dMMR (2)

MSI-H/dMMR + CD74 overexpression (2)

MSI-H/dMMR + HLA-B overexpression (2)

MSI-H/dMMR + HLA-DPA1 overexpression (2)

MSI-H/dMMR + HLA-DPB1 overexpression (2)

MSI-H/dMMR + HLA-DQA1 overexpression (2)

MSI-H/dMMR + HLA-DQB1 overexpression (2)

MSI-H/dMMR + HLA-DRB1 overexpression (2)

B2M overexpression (2)

CEACAM5 underexpression + MSI-H/dMMR (2)

MSI-H/dMMR + CD74 overexpression (2)

MSI-H/dMMR + HLA-B overexpression (2)

MSI-H/dMMR + HLA-DPA1 overexpression (2)

MSI-H/dMMR + HLA-DPB1 overexpression (2)

MSI-H/dMMR + HLA-DQA1 overexpression (2)

MSI-H/dMMR + HLA-DQB1 overexpression (2)

MSI-H/dMMR + HLA-DRB1 overexpression (2)

B2M overexpression (2)

›

B2M mutation + MSI-H/dMMR

Colorectal Cancer

Sensitive: C3 – Early Trials

Sensitive: C3 – Early Trials